Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: 22nd European Society for Animal Cell Technology (ESACT) Meeting on Cell Based Technologies

Open Access Introduction

Cell Based Technologies: Abstracts of the 22nd ESACT Meeting 2011 in Vienna

Hansjörg Hauser

Author Affiliations

Helmholtz-Zentrum für Infektionsforschung GmbH, Department of Gene Regulation and Differentiation, 38124 Braunschweig, Germany

BMC Proceedings 2011, 5(Suppl 8):I1  doi:10.1186/1753-6561-5-S8-I1

The electronic version of this article is the complete one and can be found online at:

Published:22 November 2011

© 2011 Hauser; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The European Society of Animal Cell Technology (ESACT) is a society that brings together scientists, engineers and other specialists working with animal cells in order to promote communication of experiences between European and international investigators and progress development of cell systems in productions derived from them.

Animal cells are being used as substrates in basic research and also for the production of proteins. Tissue engineering, gene and cell therapies, organ replacement technologies and cell-based biosensors contribute to a considerable widening of interest and research activity based on animal cell technology.

The abstracts of this supplement are from the 22nd ESACT meeting that was held in Vienna, Austria, May 15-18, 2011. The abstracts review the presentations from this meeting and should be a useful resource for the state-of-the-art in animal cell technology.